Literature DB >> 17619564

A retrospective study of bronchial hyperresponsiveness in patients with asthma before the onset of Churg-Strauss syndrome.

Naomi Tsurikisawa1, Takahiro Tsuburai, Hiroshi Saito, Sonoko Morita, Yoriko Horiguchi, Hiroyuki Mitomi, Kazuo Akiyama.   

Abstract

Asthma is one of the most common clinical symptoms in Churg-Strauss syndrome (CSS). However, it is not known how lung function and bronchial hyperresponsiveness (BHR) prior to the development of CSS differs from asthmatics do not develop CSS. This retrospective cohort study was conducted to predict the onset of CSS and facilitate diagnosis in the early phase of the disease. We examined 24 pre-CSS asthmatic patients and 294 non-CSS asthmatic patients for clinical features, percent forced expiratory volume at 1 second (%FEV1), BHR to acetylcholine, and evaluated eosinophils (%) in the peripheral blood at their first hospital visit for asthma treatment. All of the 24 pre-CSS patients had adult-onset asthma. The asthma of 87.5% of pre-CSS patients at the first hospital visit before the onset of CSS was severe and was complicated by sinusitis. The eosinophils (%) in the peripheral blood was significantly higher than in non-CSS asthmatic patients. The %FEV1 in both the patients with severe asthma and the patients who developed CSS was lower than in patients with mild or moderate asthma. However, BHR in pre-CSS patients was significantly better than in non-CSS patients with severe asthma and was as mild as in patients with mild asthma. Patients who developed CSS had clinically severe asthma before the onset of CSS. The severity of their asthma was related to airflow limitation and eosinophilic inflammation in the peripheral blood, but not to BHR. These findings should prove useful in future early diagnosis and treatment of CSS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619564     DOI: 10.2500/aap.2007.28.2997

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  5 in total

Review 1.  Cutting edge issues in the Churg-Strauss syndrome.

Authors:  Wojciech Szczeklik; Bogdan Jakieła; Dariusz Adamek; Jacek Musiał
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

2.  Th17 cells reflect colon submucosal pathologic changes in active eosinophilic granulomatosis with polyangiitis.

Authors:  Naomi Tsurikisawa; Chiyako Oshikata; Takahiro Tsuburai; Satoshi Sugano; Yoko Nakamura; Takuya Shimoda; Shunpei Tamama; Ken Adachi; Ayako Horita; Ikuo Saito; Hiroshi Saito
Journal:  BMC Immunol       Date:  2015-12-29       Impact factor: 3.615

3.  Can HLA-DRB4 Help to Identify Asthmatic Patients at Risk of Churg-Strauss Syndrome?

Authors:  P Bottero; F Motta; M Bonini; F Vecchio; F Ierna; I Cuppari; R A Sinico
Journal:  ISRN Rheumatol       Date:  2014-03-06

4.  An increase of CD83+ dendritic cells ex vivo correlates with increased regulatory T cells in patients with active eosinophilic granulomatosis and polyangiitis.

Authors:  Naomi Tsurikisawa; Hiroshi Saito; Chiyako Oshikata; Takahiro Tsuburai; Miyako Ishiyama; Hiroyuki Mitomi; Kazuo Akiyama
Journal:  BMC Immunol       Date:  2014-08-31       Impact factor: 3.615

5.  Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab.

Authors:  Francesco Menzella; Carla Galeone; Giulia Ghidoni; Patrizia Ruggiero; Silvia Capobelli; Anna Simonazzi; Chiara Catellani; Chiara Scelfo; Francesco Livrieri; Nicola Facciolongo
Journal:  Multidiscip Respir Med       Date:  2021-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.